New hope for hepatitis c patients who relapsed
NCT ID NCT01466192
Summary
This study tested whether adding a new drug called MP-424 to two standard hepatitis C medications could help patients who had previously relapsed after treatment. The trial involved 108 people with a specific type of hepatitis C (genotype 2) who had seen their infection return after earlier therapy. Researchers measured whether the three-drug combination could keep the virus undetectable long-term after treatment ended.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Minato-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.